VolitionRx Ltd (VNRX) - רווחיות תפעולית

VolitionRx Limited (VNRX) is implementing automated AI systems for epigenetic blood scanning. The company's revenues are based on the commercialization of Nu.Q for human and animal oncology diagnostics. The operating margin demonstrates business resilience, with -512.60 serving as the current value of this metric. Process efficiency is further enhanced by the express delivery of reagents, ensuring uninterrupted laboratory operations and high analysis speeds.
פילוחי מדדים פיננסיים ומדדי שוק עבור VolitionRx Ltd. (VNRX)

Operating margin is calculated as the ratio of operating income to revenue, reflecting the efficiency of the core business before accounting for debt load and taxes. This metric allows for an assessment of a company's ability to generate cash flow, while the operating margin of VolitionRx Limited (VNRX) is currently limited by expansion costs for Nu.Q platforms within the conservative laboratory network segment.